Drugs.com - FDA MedWatch Alerts

Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Bacterial Contamination

Audience: Healthcare Provider, Pharmacy, Consumer September 17, 2024 – Princeton, NJ, Bionpharma Inc. is voluntarily recalling (1) single Batch (2310083) of Atovaquone Oral Suspension, 750mg per mL to the consumer level. The product was...

Feb 9, 2025 - 21:44
 0
Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Bacterial Contamination
Audience: Healthcare Provider, Pharmacy, Consumer September 17, 2024 – Princeton, NJ, Bionpharma Inc. is voluntarily recalling (1) single Batch (2310083) of Atovaquone Oral Suspension, 750mg per mL to the consumer level. The product was...
Read More

Tags:

Previous Article

Drug Safety Communication: FDA Adds Warning About Rare Occurrence of Serious Liv...

Next Article

FDA Warns Consumers Not to Purchase or Use Umary and Amazy Products As They May ...

Related Posts

Do Not Purchase or Use Skin-Cap Aerosol Spray Products Because They May Be Harmful to Your Health

Do Not Purchase or Use Skin-Cap Aerosol Spray Products ...

Feb 9, 2025  0

FDA Warns Health Care Professionals Not to Use Epinephrine Nasal Solutions from BPI Labs and Endo USA

FDA Warns Health Care Professionals Not to Use Epinephr...

Feb 9, 2025  0

Endo USA, Inc. Issues Recall of One Lot of Clonazepam Orally Disintegrating Tablets Due to Mislabeling: Incorrect Strength on Product Carton

Endo USA, Inc. Issues Recall of One Lot of Clonazepam O...

Feb 9, 2025  0